Improving Pregnancy Counseling for Women with Rheumatoid Arthritis Taking Methotrexate

American Journal of Medicine

Volumn 122, Issue 11, 2009, Pages 998-1000

  Neeman, Naama ^a,b   Aronson, Mark D ^a,b,c   Schulze, Joanne E ^a,b   Shmerling, Robert H ^a,c  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b San Diego Center for Patient Safety   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE; MINOCYCLINE;

ARTICLE; BIRTH DEFECT; CLINICAL PRACTICE; DRUG DOSE REDUCTION; HEALTH PROGRAM; HUMAN; MEDICAL DOCUMENTATION; MEDICAL RECORD REVIEW; PATIENT COUNSELING; PATIENT SAFETY; PREGNANCY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; TASK PERFORMANCE; TREATMENT OUTCOME;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; COUNSELING; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; INFANT, NEWBORN; METHOTREXATE; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME;

EID: 71149090573     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2009.07.009     Document Type: Note

References (10)

1. Saag K.G., Teng G.G., Patkar N.M., et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis, 2008 update. Arthritis Rheum 59 (2008) 762
2. Chakravarty E.F., Sanchez-Yamamoto D., and Bush T.M. The use of disease modifying antirheumatic drugs in women with rheumatoid arthritis of childbearing age: a survey of practice patterns and pregnancy outcomes. J Rheumatol 30 (2003) 241
3. Ostensen M., Hartmann H., and Salvesen K. Low dose weekly methotrexate in early pregnancy. A case series and review of the literature. J Rheumatol 27 (2000) 1872
4. Kozlowski R.D., Steinbrunner J.V., MacKenzie A.H., et al. Outcome of first-trimester exposure to low-dose methotrexate in eight patients with rheumatic disease. Am J Med 88 (1990) 589
5. Ostensen M., Khamashta M., Lockshin M., et al. Anti-inflammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 8 (2006) 209
6. Buckley L.M., Bullaboy C.A.L., et al. Multiple congenital anomalies associated with weekly low-dose methotrexate treatment of the mother. Arthritis Rheum 40 (1997) 971
7. Janssen N.M., and Genta M.S. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy, and lactation. Arch Intern Med 160 (2000) 610-619
8. Maini R.N. Patient information: disease modifying antirheumatic drugs (DMARDs)UpToDate 2007. http://www.uptodate.com/patients/content/topic.do?topicKey=∼tZKOrn__cLNnQ/ Accessed Sept 1, 2009
9. Donnenfeld A.E., Pastuszak A., Noah J.S., et al. Methotrexate exposure prior to and during pregnancy. Teratology 49 (1994) 79-81
10. Aronson M.D., Neeman N., Carbo A., et al. A model for quality improvement programs in academic departments of medicine. Am J Med 121 (2008) 922-929